These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26403419)

  • 1. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
    Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
    Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
    Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
    Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.
    Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
    PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
    Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
    J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing identified a novel
    Li Y; Xie Y; Wang D; Xu H; Ye J; Yin JC; Chen J; Yan J; Ye B; Chen C
    Front Oncol; 2022; 12():963364. PubMed ID: 36387164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.
    Cho Y; Kim J; Kim Y; Jeong J; Lee KA
    Ann Lab Med; 2013 May; 33(3):212-6. PubMed ID: 23667851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.
    Güran S; Tunca Y; Imirzalioğlu N
    Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Li-Fraumeni syndrome heterogeneity.
    Gargallo P; Yáñez Y; Segura V; Juan A; Torres B; Balaguer J; Oltra S; Castel V; Cañete A
    Clin Transl Oncol; 2020 Jul; 22(7):978-988. PubMed ID: 31691207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age.
    Trkova M; Prochazkova K; Krutilkova V; Sumerauer D; Sedlacek Z
    Cancer; 2007 Aug; 110(3):694-702. PubMed ID: 17567834
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    da Silva PFF; Goveia RM; Teixeira TB; Gamba BF; de Lima AP; Rogatto SR; Silveira-Lacerda EP
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625568
    [No Abstract]   [Full Text] [Related]  

  • 20. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.